| 2018 |
The conserved C-terminal domain of RPAP3 directly binds RUVBL1/RUVBL2 hexamers, and this interaction is essential for human R2TP complex assembly; a 3.6 Å cryo-EM structure reveals direct interaction of the RPAP3 C-terminal domain with the ATPase domain of RUVBL2. The mobile TPR domains of RPAP3 map to the opposite face of the RUVBL ring, associating with PIH1D1, which mediates client protein recruitment. RPAP3 thus spans both faces of a single RUVBL ring, providing an extended scaffold that recruits clients and provides a flexible tether for HSP90. |
Cryo-EM (3.6 Å structure), biochemical studies, domain mapping |
Nature communications |
High |
29662061
|
| 2018 |
The RPAP3 C-terminal domain directly binds RUVBL1/RUVBL2 hexamers, and an RPAP3-like protein SPAG1 can bind PIH1D2 and RUVBL1/2 to form an R2TP-like complex termed R2SP. R2SP is enriched in testis, required for liprin-α2 expression, and facilitates assembly of liprin-α2 complexes, demonstrating a quaternary protein folding function. |
Structural analysis (RPAP3-C domain), systematic interaction analyses (co-IP, pulldown), functional knockdown assays |
Nature communications |
High |
29844425
|
| 2010 |
In yeast, the Pih1-Tah1 (RPAP3 ortholog) heterodimer binds Hsp90 with similar affinity and stoichiometry as Tah1 alone, but the Pih1-Tah1 complex inhibits Hsp90 ATPase activity, antagonizing the stimulatory effect of Tah1 alone. Pih1 alone is unstable and degraded from its N terminus, but forms a stable heterodimer with Tah1. |
Analytical ultracentrifugation, microcalorimetry, noncovalent mass spectrometry, ATPase activity assay |
The Journal of biological chemistry |
High |
20663878
|
| 2008 |
Yeast Tah1 (RPAP3 ortholog) specifically binds Hsp90 (yeast Hsp90, human Hsp90α and Hsp90β) via the conserved MEEVD motif at the Hsp90 C-terminus, but does not bind yeast Hsp70 (Ssa1). Ligand discrimination is achieved by favourable binding of the methionine in MEEVD and positive discrimination against the first valine in the Hsp70 VEEVD motif. Tah1 can affect Hsp90 ATPase activity. |
Binding assays (chaperone specificity), mutagenesis, ATPase activity assay |
The Biochemical journal |
Medium |
18412542
|
| 2011 |
NMR structure of yeast Tah1 (RPAP3 ortholog) reveals two TPR motifs, a C helix, and an unstructured C-terminal region. Tah1 binds Hsp90 via the EEVD C-terminal residues through a positively charged channel with a two-carboxylate clamp. Tah1 binds the C-terminus of Pih1 through its C helix and unstructured region, stabilizing Pih1; the C-terminus of Pih1 destabilizes the protein in vitro and in vivo, and Tah1 binding allows stable complex formation. |
NMR structure determination, binding assays, mutagenesis, in vitro/in vivo stability assays |
The Journal of biological chemistry |
High |
22179618
|
| 2013 |
High-resolution NMR solution structures of Tah1 free and in complex with the Hsp90 C-terminal peptide show that the TPR fold is similar in free and bound forms. The capping helix is essential for recognition of the Hsp90 EMEEVD motif, with Lys79, Arg83 (carboxylate clamp), and Tyr82 (π/S-CH3 interaction with Hsp90 M705) identified as key contacts. The Tah1 C-terminal unfolded region is essential for recruitment of the Pih1 C-terminal domain and folds upon binding. |
NMR structure (free and peptide-bound), mutagenesis, binding validation |
Structure |
High |
24012479
|
| 2014 |
Drosophila Spag (RPAP3 ortholog) binds Drosophila orthologs of R2TP components and Hsp90, and also interacts with and stimulates the chaperone activity of Hsp70. Spag is necessary for stabilization of snoRNP core proteins, TOR signaling activity, and likely the assembly of RNA polymerase II. Interaction with both Hsp70 and Hsp90 suggests R2TP accompanies clients from Hsp70 to Hsp90 for assembly into macromolecular complexes. |
Co-immunoprecipitation, RNAi knockdown/null mutants, chaperone activity assay, functional phenotype analysis |
The Journal of biological chemistry |
Medium |
24394412
|
| 2009 |
RPAP3 interacts with Reptin (RUVBL2), a component of chromatin-remodeling complexes, as shown by immunoprecipitation and confocal microscopy. Overexpression of RPAP3 increases cell death after UV irradiation; RNAi-mediated knockdown of RPAP3 improves HeLa cell survival after UV damage and attenuates H2AX phosphorylation, while depletion of Reptin reduces survival and facilitates H2AX phosphorylation. |
Affinity purification/mass spectrometry, co-immunoprecipitation, confocal microscopy, RNAi knockdown, UV survival/H2AX phosphorylation assays |
Journal of cellular biochemistry |
Medium |
19180575
|
| 2012 |
RPAP3 isoform 1 (but not isoform 2) interacts with PIH1D1 and is required for PIH1D1 protein stability; RPAP3 isoform 1 knockdown downregulates PIH1D1 protein without affecting PIH1D1 mRNA. RPAP3 isoform 2 potentiates doxorubicin-induced cell death, suggesting a dominant negative effect on R2TP complex survival function. |
Co-immunoprecipitation, siRNA knockdown, mRNA/protein level analysis, cell death assays |
Biochemical and biophysical research communications |
Medium |
23159623
|
| 2010 |
RPAP3 binds NEMO (NF-κB essential modulator) and inhibits NEMO ubiquitination, thereby impairing NF-κB pathway activation and enhancing doxorubicin-induced cell death in breast cancer cells. |
Co-immunoprecipitation, ubiquitination assay, cell death assay, NF-κB pathway analysis |
Biochemical and biophysical research communications |
Low |
21184742
|
| 2022 |
The R2TP component RPAP3-TPR1 domain directly binds the TRBP-dsRBD3 domain; a 1.5 Å crystal structure identifies key residues involved. Binding of TRBP to RPAP3 and binding of TRBP to Dicer are mutually exclusive. AGO1/2, TRBP, and Dicer are sensitive to HSP90 inhibition; TRBP sensitivity is increased in the absence of RPAP3, suggesting RPAP3 modulates miRNA pathway via TRBP sequestration. |
Crystal structure (1.5 Å), co-immunoprecipitation, competitive binding assay, HSP90 inhibition, RPAP3 knockdown |
Nucleic acids research |
High |
35150569
|
| 2022 |
RPAP3 is phosphorylated at Ser116, Ser119, and Ser121 by kinase CK2 in HEK293 cells; the unphosphorylated form of RPAP3 binds ribosomal preassembly complexes. Phospho-null mutations at these sites enhance RPAP3 binding to proteins involved in ribosome biogenesis in AP-MS experiments, and pharmacological inhibition of CK2 similarly enhances this binding. PAQosome subunit silencing interferes with ribosomal assembly factor interactome. |
AP-MS (affinity purification-mass spectrometry), in vitro phosphorylation assays, phospho-null mutagenesis, CK2 inhibitor treatment, siRNA knockdown |
Journal of proteome research |
Medium |
35129352
|
| 2021 |
Yeast Tah1 (RPAP3 ortholog) interacts with Hsp70 (Ssa1) and with Ure2, improves Ure2 solubility in [URE3] strains, and inhibits Ure2 fibrillation in vitro. The N-terminal TPR domain of Tah1 is indispensable for [URE3] curing. Tah1 overproduction cures [URE3] prion and tah1 deletion increases de novo [URE3] appearance, placing Tah1 in prion propagation control. |
Genetic overexpression/deletion, in vitro fibrillation assay, co-immunoprecipitation, prion frequency assays, domain mutagenesis |
Journal of molecular biology |
Medium |
33811921
|
| 2015 |
Drosophila Spag (RPAP3 ortholog) antagonizes DBT (CKIε/δ ortholog) C-terminal autophosphorylation in S2 cells, as shown by Spag overexpression reducing DBT electrophoretic mobility shifts indicative of autophosphorylation. |
S2 cell overexpression, electrophoretic mobility shift assay, mass spectrometry of phosphorylation sites |
Molecular and cellular biology |
Low |
25939385
|
| 2025 |
CCDC103 binds RUVBL1-RUVBL2 via a RUVBL2-binding domain (RBD) homologous to the RPAP3 C-terminal domain, but unlike RPAP3, CCDC103 lacks PIH1D1-binding motif and TPR domains. The cryo-EM structure of the RUVBL1-RUVBL2-CCDC103 complex (R2C) at 3.2 Å shows three CCDC103 molecules bound to a hetero-hexameric RUVBL1-RUVBL2 ring, with the flexible N-terminal region of CCDC103 regulating RUVBL1-RUVBL2 oligomerisation. This defines the structural distinction between R2C and R2TP (which uses RPAP3). |
Cryo-EM structure (3.2 Å), biochemical characterization |
bioRxivpreprint |
Medium |
bio_10.1101_2025.09.11.675549
|